Cost-effectiveness analyses of breast cancer medications use in developing countries: a systematic review.
Nour Hisham Al-ZiftawiAsrul Akmal ShafieMohamed Izham Mohamed IbrahimPublished in: Expert review of pharmacoeconomics & outcomes research (2020)
In many studies included in the review, the use of breast-cancer drugs in developing countries was not cost-effective. Yet, more pharmacoeconomic evaluations for the use of recently approved agents in different disease stages are needed in developing countries.